Compare Amgen, Inc. (AMGN) vs Equinix Inc (EQIX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amgen, Inc. vs Equinix Inc — how do they compare? Amgen, Inc. trades at $360.87 (market cap $196.12B), while Equinix Inc trades at $1,046.81 (market cap $103.67B). The key difference: Amgen, Inc. is the larger of the two by market cap, and Amgen, Inc. pays the higher dividend (2.77%). Which is the better fit depends on your goals.
| AMGN | EQIX | |
|---|---|---|
Market Cap | $196.12B | $103.67B |
Sector | Health | Real Estate |
52-Week High | $388.16 | $1.12K |
52-Week Low | $271.18 | $726.09 |
Enterprise Value | $241.41B | $123.96B |
Dividend Yield | 2.77% | 1.87% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMGN trades at $363.39, down slightly by 0.06% today, with a bullish technical signal from moving averages. The company reported strong Q1 2026 earnings, beating estimates with EPS of $5.15 versus $4.77 expected. Revenue grew to $36.75B in 2025, with a net income margin of 20.96%. Recent news includes a favorable court ruling blocking a price cap on Enbrel in Colorado, but regulatory challenges persist for Tavneos in Europe.
The outlook remains positive due to consistent earnings beats and a diversified product portfolio, though risks include regulatory setbacks and competitive pressures. Analyst consensus is bullish with a 57.9% buy rating and a price target of $357.38, slightly below the current price, indicating potential for stability with upside from pipeline developments.
Equinix (EQIX) trades at $1,051.21, up 1.58% with a bearish technical signal despite strong analyst support. The data center REIT shows solid revenue growth to $9.22B in 2025 and expanding profit margins of 15.07%, though valuation metrics remain elevated with a P/E of 72.7. Recent partnerships with Cisco and NVIDIA position EQIX to capitalize on AI infrastructure demand, while negative cash flow trends and rising debt-to-asset ratios present financial concerns.
The outlook balances AI-driven growth potential against valuation and leverage risks. With 74.5% analyst buy ratings and a $1,120 consensus price target suggesting 6.5% upside, institutional sentiment remains positive. However, investors face execution risks in capital-intensive expansion and sensitivity to interest rate changes given the REIT structure and substantial debt load.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amgen, Inc.
Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amgevita (biosimilar Humira).
Read more on AMGN →About Equinix Inc
Equinix is a retail provider of data centers, enabling hundreds of enterprise tenants to house their servers and networking equipment in a collocated environment. Tenants can then connect with each other, through cloud service providers and telecom networks. Equinix operates 240 data centers in 66 markets worldwide and owns just less than half of them. The firm has roughly 10,000 customers, including 2,000 networks, that are dispersed over five verticals: Cloud and IT Services, Content Providers, Network and Mobile Services, Financial Services, and Enterprise. About 70% of Equinix's revenue comes from renting space to tenants and related services, and more than 15% comes from connecting customers with each other. Equinix operates as a real estate investment trust.
Read more on EQIX →
